Skip to content

Rhythm Pharmaceuticals, Inc. RYTM Operating Lease ROU Assets

Operating Lease ROU Assets at other companies

Arrowhead Research logo
Arrowhead ResearchARWR
$42.79M-3.7%
Alkermes logo
AlkermesALKS
$78.25M-5.0%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$1.32M+49.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$17.23M+140%
TG Therapeutics logo
TG TherapeuticsTGTX
$6.48M-6.4%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K
Free cash flow-$29.2M-2.4%

Valuation

See full
Market cap$6.64B+77.3%
Enterprise value$6.69B+78.4%
P/S30.6×+3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Reported directly by Rhythm Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rhythm Pharmaceuticals, Inc.'s operating lease rou assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets?
Rhythm Pharmaceuticals, Inc. (RYTM) reported operating lease ROU assets of $2.94M in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets decreased by 12.8% year-over-year, from $3.37M to $2.94M.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets?
Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s operating lease ROU assets has grown at a 11.0% compound annual growth rate (CAGR), from $1.81M to $3.05M.
What does operating lease ROU assets mean?
Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.